好色先生

好色先生

Explore the latest content from across our publications

Log In

Forgot Password?
Create New Account

Loading... please wait

Abstract Details

Comparing the Efficacy and Safety of Endovascular Therapy versus Best Medical Treatment in Patients with Distal Medium Vessel Occlusion: A Systematic Review and Meta-analysis
Cerebrovascular Disease and Interventional Neurology
S44 - Evidence-based Stroke Interventions and Prognostic Tools (1:36 PM-1:48 PM)
004

This meta-analysis aims to compare the efficacy and safety of endovascular therapy (EVT) with the best medical treatment (BMT) in patients with Distal Medium Vessel Occlusions (DMVOs).

DMVOs represent a significant subset of Acute Ischemic Stroke (AIS), with unique treatment challenges due to vessel size and location. While EVT shows promise, its efficacy compared to BMT remains unclear.

PubMed, Cochrane Central, and ScienceDirect were searched from inception till May 2025. Categorical data were pooled as risk ratios (RR) using the Review Manager software under random effects model. The excellent functional outcome was defined as modified Rankin Scale (mRS) score of 0-1 whereas functional independence was defined as mRS score of 0-2. Neurological improvement is defined as a decrease of four or more points in the National Institutes of Health Stroke Scale (NIHSS) score. Alternatively, neurological deterioration is defined as an NIHSS score increase of ≥4 points 24 hours after admission.

Thirty-seven studies pooling a total of 9,505 patients were included. The excellent functional outcome was comparable between both the EVT and BMT arms (RR= 1.04;95%CI:[0.96, 1.13]; p= 0.34; I2= 59%). Similarly, the functional independence showed no significant difference between the two groups (RR= 1.00;95%CI:[0.94, 1.06]; p= 0.99; I2= 64%). The 90-day mortality (RR= 1.21;95%CI:[0.97, 1.52]; p= 0.09; I2= 46%) and neurological deterioration (RR= 1.39;95%CI:[0.65, 2.95]; p= 0.40; I2= 82%) were also comparable between the two arms. EVT showed a statistically significant increase in neurological improvement (RR= 1.38;95%CI:[1.05, 1.82]; p= 0.02; I2= 53%), although it was associated with a high risk of symptomatic intracranial hemorrhage (sICH) (RR= 1.56;95%CI:[1.15, 2.13]; p= 0.005; I2= 39%).

EVT was associated with a significant increase in the early neurological improvement although the risk of sICH was high. Other safety and efficacy outcomes including excellent functional outcome, functional independence, all-cause mortality and neurological deterioration were comparable.

Authors/Disclosures
Muhammad W. Ansari, MD (UTMB)
PRESENTER
Dr. Ansari has nothing to disclose.
Hassan Waseem Hassan Waseem has nothing to disclose.
Zain ul Abideen, MBBS Dr. ul Abideen has nothing to disclose.
Eeshal Zulfiqar, MBBS Ms. Zulfiqar has nothing to disclose.
Barka Sajid, MBBS Dr. Sajid has nothing to disclose.
Aisha Kakakhail Dr. Kakakhail has nothing to disclose.
Haider Kashif, MBBS Dr. Kashif has nothing to disclose.
Muhammad Ansab, MBBS Dr. Ansab has nothing to disclose.
Muhammad S. Ansari, MBBS Dr. Ansari has nothing to disclose.
Rowaid Ahmad, MBBS Dr. Ahmad has nothing to disclose.
Justin Chen Mr. Chen has nothing to disclose.
Jamir Pitton Rissardo, MD Dr. Pitton Rissardo has nothing to disclose.
Ana Leticia Fornari Caprara, MD Dr. Fornari Caprara has nothing to disclose.
Vishnu V. Byroju, MD (Cooper University Healthcare) Dr. Byroju has nothing to disclose.
Adam Dmytriw (Massachusetts General Hospital) Adam Dmytriw has nothing to disclose.
Brandon Lucke-Wold Mr. Lucke-Wold has nothing to disclose.